2
项与 度拉纳明(Shanghai Gebaide Biotechnology Co., Ltd.) 相关的临床试验注射用重组人凋亡素2配体治疗晚期非小细胞肺癌随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
观察和评价注射用重组人凋亡素2配体对晚期复治非小细胞肺癌患者的有效性和安全性
A Randomized, Double-blind, Placebo-controlled in Parallel, Multicenter Phase III Trial of Recombinant Human Apo-2 Ligand for Injection(Dulanermin for Injection)in the Treatment of Advanced Non-small Cell Lung Cancer
The trial is to evaluate the efficacy and safety of recombinant human Apo-2 ligand in treating patients with advanced retreated non-small cell lung cancer
100 项与 度拉纳明(Shanghai Gebaide Biotechnology Co., Ltd.) 相关的临床结果
100 项与 度拉纳明(Shanghai Gebaide Biotechnology Co., Ltd.) 相关的转化医学
100 项与 度拉纳明(Shanghai Gebaide Biotechnology Co., Ltd.) 相关的专利(医药)
100 项与 度拉纳明(Shanghai Gebaide Biotechnology Co., Ltd.) 相关的药物交易